Driving Cardiac Valve Market Growth in 2025: The Role of Cardiac Valve Market Expansion Addressing The Growing Burden Of Heart-Related Ailments

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Cardiac Valve Market Size Growth Forecast: What to Expect by 2025?
The size of the cardiac valve market has witnessed a swift expansion in recent years. The expectation is for it to rise from $10.89 billion in 2024 to $12.48 billion in 2025, with a compound annual growth rate (CAGR) of 14.6%. Factors contributing to the growth during the historic period include the aging population and the consequent rise in valvular heart disease, an increase in risk determinants like obesity and hypertension, advancements in diagnostic and imaging technology for valve disorders, public awareness drives and heart health and valve disease education, along with progress in minimally invasive and transcatheter valve operations.

How Will the Cardiac Valve Market Size Evolve and Grow by 2029?
The size of the cardiac valve market is predicted to experience significant expansion in the upcoming years. The expectation is that it will rise to a value of $21.26 billion in 2029, with a compound annual growth rate (CAGR) of 14.2%. The projected growth within this period is due to the rising demand for bioengineered and tissue-engineered heart valves, an aging global population and the necessity for treatments for valve diseases. The introduction of telemedicine and remote patient monitoring for valve patients, improved surgical techniques, robotics-assisted valve procedures, and the employment of 3D printing for customized heart valve production also contribute to this growth. Key trends for the forecasted period encompass progress in valve replacement and repair practices, the use of artificial intelligence (AI) for valve disease diagnosis and treatment plans, the continued use of 3D printing for custom heart valve production, improvements in valve replacement and repair methods, and the development of surgical techniques and robotics-assisted valve procedures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

What Drivers Are Propelling the Growth of Cardiac Valve Market Forward?
The accelerating rate of cardiovascular illnesses is anticipated to boost the enlargement of the cardiac valve sector. The occurrence of cardiovascular ailments is on a steady upsurge, prompted by factors such as obesity, smoking, sedentary lifestyle, and other stressors on the heart system. Accumulation of fatty substances in arteries is the prevalent cause of coronary artery maladies. This steady escalation in heart-related conditions escalates the need for cardiac valves to rectify heart valve issues. For instance, the World Health Organization, a specialized branch of the United Nations based in Switzerland, revealed in September 2023 that out of 41 million global deaths annually due to non-communicable diseases (NCDs) or chronic ailments, 74% were accounted for. These included 17.9 million deaths from cardiovascular ailments, 9.3 million deaths from cancer, 4.1 million deaths from persistent respiratory ailments, and 2.0 million deaths from diabetes. Therefore, the accelerating rate of cardiovascular conditions is anticipated to stimulate the enlargement of the cardiac valve sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp

Which Emerging Trends Are Transforming the Cardiac Valve Market in 2025?
The cardiac valve market is witnessing a growing trend of technological advancements. Less invasive treatments for heart diseases are now possible due to these enhancements in technology. Large firms in the cardiac valve industry are focusing on innovative technologies like neochordae implantation, annuloplasty ring, and robotic surgery to solidify their market standing. These groundbreaking technologies aid in safeguarding patients from potentially fatal situations like a heart stroke or a cardiac arrest. For example, Edwards, a medical technology firm based in the US, in September 2022, launched the Sapien 3 Ultra Resilia transcatheter heart valve that features anti-calcification technology. This particular technology was created to permanently block calcium binding sites in bioprosthetic valves.

What Are the Key Segments in the Cardiac Valve Market?
The cardiac valve market covered in this report is segmented -

1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users

Subsegments:
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Implantation (TAVI) Valves, Transcatheter Mitral Valve Repair Valves
3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves
4) By Other Types: Conduits, Stented vs. Stentless Valves

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7753&type=smp

Who Are the Key Players Shaping the Cardiac Valve Market's Competitive Landscape?
Major companies operating in the cardiac valve market include Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, Jenavalve Technology Inc., CryoLife Inc., Lepu Medical Technology Co. Ltd., Braile Biomedical, Sorin Group, Micro Interventional Devices Inc., Medtronic Inc., Lepu Medical Technology, Edward Lifesciences Corporation, Xeltis AG, Meril Life Sciences Pvt. Ltd., Auto Tissue Berlin GmbH, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.

What Geographic Markets Are Powering Growth in the Cardiac Valve Market?
North America was the largest region in the cardiac valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7753

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.